TRAPPC1

TRAPPC1 (BET5/Bet5p) is an essential core subunit of the multisubunit TRAPP complex that drives ER-to-Golgi vesicular transport (PMID:9611195). As part of the assembled complex, it contributes to guanine nucleotide exchange factor (GEF) activity toward the Rab GTPase Ypt1p/Rab1: the TRAPP complex preferentially binds the nucleotide-free form of Ypt1p and accelerates GDP/GTP exchange, and temperature-sensitive Bet5p mutations impair GDP displacement (PMID:11038176). TRAPPC1 partners with Bet3p within the complex, and its function is genetically embedded in the ER-to-Golgi pathway alongside BET1, SEC22, USO1 and DSS4 (PMID:9611195); the human ortholog (MUM-2) functionally complements yeast bet5 loss, establishing cross-eukaryotic conservation of this role (PMID:10582700). Loss of TRAPPC1 disrupts ER-to-Golgi protein trafficking and alters Golgi morphology, triggering ER stress and the unfolded protein response that converge on cell death and impaired differentiation across multiple lineages — Atf4-CHOP apoptosis and ROS-driven ferroptosis in thymic epithelial cells (PMID:35908180), p53/lipid-peroxide-dependent ferroptosis in naive T cells (PMID:38234007), and Ca2+-mitochondria apoptosis plus PERK/p21 senescence in myeloid progenitors (PMID:36440617). Biallelic TRAPPC1 variants in an affected individual cause membrane trafficking and Golgi defects in patient fibroblasts that are rescued by wild-type TRAPPC1, linking the gene to a human disorder of secretion and autophagy (PMID:39273027).

1. 1998 High

   Established that Bet5p/TRAPPC1 is required for ER-to-Golgi transport and acts within a defined secretory pathway, answering where in the secretory route this subunit functions.

   Evidence Temperature-sensitive bet5-1 mutant analysis, high-copy suppressor screen, and carboxypeptidase Y/alpha-factor transport assays in yeast

   PMID:9611195

   Open questions at the time

   • Did not define the biochemical activity of the complex
   • Did not identify the GTPase target
   • Subunit composition and stoichiometry not resolved
2. 1999 Medium

   Demonstrated that the human ortholog can substitute for yeast Bet5p, establishing functional conservation of TRAPPC1 across eukaryotes.

   Evidence Yeast bet5 deletion complementation by wild-type and mutant human MUM-2/TRAPPC1 alleles

   PMID:10582700

   Open questions at the time

   • Single lab, single complementation readout
   • No biochemical characterization of the human protein
   • Melanoma-associated point mutation had no functional effect, leaving its relevance unclear
3. 2000 High

   Identified the molecular activity of the TRAPP complex — GEF activity toward Ypt1p — and showed Bet5p is functionally required, answering how the complex acts on Rab signaling.

   Evidence In vitro nucleotide exchange assays with purified TRAPP complex, binding to nucleotide-free Ypt1p, and temperature-sensitive Bet5p mutant analysis

   PMID:11038176

   Open questions at the time

   • Did not isolate the catalytic contribution of TRAPPC1 alone
   • Structural basis of nucleotide exchange not resolved
   • Mammalian Rab1 GEF activity not directly tested
4. 2014 Medium

   Provided structural insight that the Bet5/TRAPPC1 family adopts a longin fold serving as an interaction interface, addressing how the subunit assembles into the complex.

   Evidence X-ray crystallography of the related Tca17 at 1.8 Å with structural comparison to the Bet5/TRAPPC1 family

   PMID:24961828

   Open questions at the time

   • Inference is from a related subunit, not a TRAPPC1 structure
   • Specific TRAPPC1 contact residues not experimentally mapped
   • Role of the fold in GEF catalysis untested
5. 2022 Medium

   Connected TRAPPC1 loss to defined cellular pathology, showing that disrupted ER-to-Golgi transport triggers ER stress/UPR and converging death pathways in tissue-specific contexts.

   Evidence Tissue-specific conditional Trappc1 knockout mice (thymic epithelial cells; inducible myeloid-progenitor KO with bone marrow chimeras), RNA-seq, and assays for UPR, apoptosis, ferroptosis, Ca2+/mitochondria, PERK and p21

   PMID:35908180 PMID:36440617

   Open questions at the time

   • Single lab per study
   • Direct link from trafficking defect to specific death effector not fully dissected
   • Whether phenotypes reflect TRAPP GEF activity loss versus other functions unresolved
6. 2024 Medium

   Extended the loss-of-function consequences to peripheral T cell survival and to a human disorder, showing trafficking failure drives ferroptosis/autoinflammation and that patient variants impair secretion and autophagy.

   Evidence CD4cre-Trappc1 conditional KO mice with adoptive transfer and lipid-peroxidation rescue; humanized yeast modeling of patient variants plus patient fibroblast trafficking/Golgi rescue with wild-type TRAPPC1

   PMID:38234007 PMID:39273027

   Open questions at the time

   • Disease characterization based on a single affected individual
   • Mechanistic link between trafficking defect and p53/lipid-peroxide axis incompletely defined
   • Autophagy contribution versus secretory defect not separated

• How TRAPPC1's longin fold contributes catalytically to Rab1 nucleotide exchange in the mammalian complex, and which downstream effector links its loss to lineage-specific apoptosis versus ferroptosis, remain unresolved.
• No structure of the human TRAPPC1 within the assembled GEF
• No direct measurement of TRAPPC1's individual contribution to mammalian Rab1 exchange
• Effector selecting apoptosis versus ferroptosis across cell types unidentified